Advate Alternatives Compared
Advate | Recombinate | Antihemophilic factor |
|
---|
Advate antihemophilic factor | Recombinate antihemophilic factor | Antihemophilic factor |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescribed for Hemophilia A. Advate may also be used for purposes not listed in this medication guide. |
Prescribed for Hemophilia A. Recombinate may also be used for purposes not listed in this medication guide. |
Prescribed for Hemophilia A. antihemophilic factor may also be used for purposes not listed in this medication guide. |
Choose a suggestion below Hemophilia A
|
|||||||||||||||
More about Advate (antihemophilic factor) | More about Recombinate (antihemophilic factor) | More about Antihemophilic factor | ||||||||||||||||
Generic Status | ||||||||||||||||||
No lower-cost generic available |
No lower-cost generic available |
No lower-cost generic available |
||||||||||||||||
Availability | ||||||||||||||||||
Prescription only |
Prescription only |
Prescription only |
||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Advate has an average rating of 9.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Recombinate has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Antihemophilic factor has an average rating of 7.2 out of 10 from a total of 5 ratings on Drugs.com. 80% of reviewers reported a positive effect, while 20% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
See the full Advate side effects document. |
Common side effects include: pruritus, skin rash, urticaria. See the full Recombinate side effects document. |
Commonly reported side effects include: pruritus, skin rash, urticaria. See the full antihemophilic factor side effects document. |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Advate prices |
View all Recombinate prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||
|
|
N/A | ||||||||||||||||
Brand Names | ||||||||||||||||||
Other antihemophilic factor brands include: Adynovate, Afstyla, Beriate P, Bioclate, Biostate, Eloctate, Esperoct, Factane, Fanhdi, Genarc, Helixate FS, Hemofil-M, Hyate:C, Jivi, Koate, Koate-DVI, Kogenate FS, Kovaltry, Monoclate-P, NovoEight, Nuwiq, Obizur, Recombinate, Xyntha View more | Other antihemophilic factor brands include: Advate, Adynovate, Afstyla, Beriate P, Bioclate, Biostate, Eloctate, Esperoct, Factane, Fanhdi, Genarc, Helixate FS, Hemofil-M, Hyate:C, Jivi, Koate, Koate-DVI, Kogenate FS, Kovaltry, Monoclate-P, NovoEight, Nuwiq, Obizur, Xyntha View more | Advate, Adynovate, Afstyla, Beriate P, Bioclate, Biostate, Eloctate, Esperoct, Factane, Fanhdi, Genarc, Helixate FS, Hemofil-M, Hyate:C, Jivi, Koate, Koate-DVI, Kogenate FS, Kovaltry, Monoclate-P, NovoEight, Nuwiq, Obizur, Recombinate, Xyntha View more | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
24 hours |
24 hours |
24 hours |
||||||||||||||||
CSA Schedule** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 4 drugs are known to interact with Advate:
|
A total of 4 drugs are known to interact with Recombinate:
|
A total of 4 drugs are known to interact with antihemophilic factor:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.